Pds Planning, Inc Medtronic PLC Transaction History

Pds Planning, Inc

$1.1 Billion
Q3 2024

A detailed history of Pds Planning, Inc transactions in Medtronic PLC stock. As of the latest transaction made, Pds Planning, Inc holds 2,561 shares of MDT stock, worth $208,388. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,561

Previous 3,454 25.85%

Holding current value

$208,388

Previous $271,000 15.13%

% of portfolio

0.02%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$76.84 - $91.03 $68,618 - $81,289	-893 Reduced 25.85%	2,561 $230,000
Q2 2024 Aug 07, 2024	BUY	$78.71 - $87.02 $84,534 - $93,459	1,074 Added 45.13%	3,454 $271,000
Q1 2024 May 01, 2024	BUY	$82.84 - $88.09 $197,159 - $209,654	2,380 New	2,380 $207,000
Q3 2023 Oct 20, 2023	SELL	$78.22 - $90.4 $31,679 - $36,612	-405 Reduced 11.62%	3,081 $241,000
Q2 2023 Jul 20, 2023	BUY	$79.47 - $91.38 $33,774 - $38,836	425 Added 13.88%	3,486 $307,000
Q1 2023 May 01, 2023	BUY	$76.72 - $87.58 $234,839 - $268,082	3,061 New	3,061 $246,000
Q2 2022 Jul 15, 2022	SELL	$87.4 - $113.09 $41,340 - $53,491	-473 Reduced 18.0%	2,155 $193,000
Q1 2022 Apr 18, 2022	BUY	$100.58 - $112.38 $264,324 - $295,334	2,628 New	2,628 $292,000
Q4 2021 Jan 25, 2022	SELL	$99.53 - $127.75 $212,397 - $272,618	-2,134 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$122.75 - $135.17 $20,990 - $23,114	171 Added 8.71%	2,134 $267,000
Q2 2021 Jul 26, 2021	BUY	$118.19 - $131.5 $14,537 - $16,174	123 Added 6.68%	1,963 $244,000
Q1 2021 Apr 20, 2021	BUY	$111.18 - $119.74 $9,783 - $10,537	88 Added 5.02%	1,840 $217,000
Q4 2020 Jan 21, 2021	BUY	$100.57 - $117.14 $176,198 - $205,229	1,752 New	1,752 $205,000

Others Institutions Holding MDT

# of Institutions

2,289

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pds Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pds Planning, Inc with notifications on news.

Account